Status:
COMPLETED
Controlled Trial of Prenatal Vitamin D3 Supplementation to Prevent Vitamin D Deficiency in Mothers and Their Infants
Lead Sponsor:
Children's Hospital Medical Center, Cincinnati
Collaborating Sponsors:
United Arab Emirates University
Thrasher Research Fund
Conditions:
Vitamin D Deficiency
Eligibility:
FEMALE
18-45 years
Phase:
PHASE3
Brief Summary
The purpose of this research study is to compare the effects of higher dose vitamin D with commonly recommended dose in pregnant women to see which is better in achieving and/or maintaining sufficient...
Detailed Description
Three dosages of Vitamin D will be administered; 400IU, 2000IU and 4000IU per day to pregnant women starting at less than 16 week gestation continued until delivery. The dose will be provided using a ...
Eligibility Criteria
Inclusion
- Women who are within the ages of 18-45 years
- In good general health
- 12 weeks pregnant (based on last menstrual period)
Exclusion
- Mothers with preexisting type I or type II diabetes
- Mothers with preexisting hypertension
- Mothers with preexisting parathyroid disease or uncontrolled thyroid disease
- Mothers with multiple fetuses (e.g., twins, triplets, etc.)
Key Trial Info
Start Date :
January 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2012
Estimated Enrollment :
192 Patients enrolled
Trial Details
Trial ID
NCT00610688
Start Date
January 1 2008
End Date
April 1 2012
Last Update
October 19 2021
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio, United States, 45229
2
United Arab Emirated Unitersity
Al Ain City, Abu Dhabi Emirate, United Arab Emirates